Cellex
Payments companies reported to CMS as associated with Cellex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cellex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cellex
These are the largest totals companies reported as associated with Cellex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Oleg Akilov | Pittsburgh, PA | Dermatology | $94,391.48 |
| Antonio Lombardi | Rahway, NJ | Endocrinology, Diabetes & Metabolism | $82,800.00 |
| Melhem Solh | Atlanta, GA | $67,429.53 | |
| Ahmed Galal | Morristown, NJ | Hematology (Internal Medicine) | $32,659.08 |
| Kelly Mccaul | Sioux Falls, SD | Hematology & Oncology | $29,831.66 |
| Daniel Aires | Kansas City, KS | Dermatology | $20,045.20 |
| David Sayah | Los Angeles, CA | Pulmonary Disease | $14,928.36 |
| Amin Alousi | Houston, TX | Internal Medicine | $14,305.40 |
| Vibha Lama | Ann Arbor, MI | Pulmonary Disease | $13,660.08 |
| Anthony Fernandez | Cleveland, OH | Dermatology | $8,858.40 |
Prescribed Cellex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.